Data on synthesis, ADME and pharmacological properties and early safety pharmacology evaluation of a series of novel NURR1/NOT agonist potentially useful for the treatment of Parkinson's disease
-
Published:2019-12
Issue:
Volume:27
Page:104057
-
ISSN:2352-3409
-
Container-title:Data in Brief
-
language:en
-
Short-container-title:Data in Brief
Author:
Malanda André,
Abécassis Pierre-Yves,
Barnéoud Pascal,
Brunel Pascale,
Taupin Véronique,
Vigé Xavier,
Lesuisse DominiqueORCID
Subject
Multidisciplinary
Reference10 articles.
1. Development of a novel NURR1/NOT agonist from hit to lead and candidate for the potential treatment of Parkinson's disease;Lesuisse;Bioorg. Med. Chem. Lett,2019
2. Studies on the imidazo[1,2a]pyridinic system : synthesis of pyrido[1’2’ :1,2]imidazo[5,4-d][1,3]-nezodiazepines;Teulade;Chem. Pharm. Bull.,1989
3. Bis-Cationic heteroaromatics as macrofilaricides: synthesis of bis-amidine and bis-guanylhydrazone derivatives of substituted Imidazo[1,2-a]pyridines;Sundberg;J. Med. Chem.,1998
4. US Patent 2010/0317675 A1, Dec.16, 2010.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献